Renowned Bone Health Experts To Lead Interactive Sessions At The World Congress On Osteoporosis 2010

Main Category: Bones / Orthopedics
Also Included In: Arthritis / Rheumatology;  Conferences
Article Date: 31 Mar 2009 - 3:00 PDT

email to a friend   printer friendly   opinions  

The International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) will hold a joint global congress, IOF WCO- ECCEO10, in Florence, Italy from May 5-8, 2010.

Complete programme information, online registration and abstract submission will be available on http://www.iofwco-ecceo10.org .

IOF WCO-ECCEO10 will be an excellent forum for interaction and the exchange of ideas among researchers and clinicians as well as specialists from allied health fields. It will offer an overview of the most recent developments and cutting-edge research in the pathophysiology, diagnosis, prevention and treatment of osteoporosis and osteoarthritis, as well as policy related issues such as health economics.

Offering a broad global perspective, the scientific programme will provide a mix of stimulating plenary lectures on 'hot' topics in the field and more clinically-oriented meet-the-expert sessions led by world experts. There will also be poster presentations, late breaking news, satellite symposia, and a large exhibition area.

Meet-the-expert sessions to be led by world experts:

Each day specialists will lead exchanges on 20 key topics. Small groups, on a first come first served basis, will be encouraged to not only ask questions but to also provide feedback about their own experiences. The following topics and speakers are scheduled:

• Assessing bone strength beyond DXA, C. Glüer (Germany)
  
  
• Optimal dose of vitamin D, B. Dawson-Hughes (USA)
  
  
• Muscle and bone interaction, D. Felsenberg (Germany)
  
  
• Practical approach of glucocorticoid-treated patients, J. Adachi (Canada)
  
  
• Health economics and treatment selection, J-Y. Reginster (Belgium)
  
  
• BMU balance: effects of anti-osteoporotic agents, J.Compston (UK)
  
  
• Premenopausal osteoporosis, E. Siris (USA)
  
  
• Bone mass/structure measurements during growth, R. Rizzoli (Switzerland)
  
  
• Bone disease in primary hyperparathyroidism, J.P. Bilezikian (USA)
  
  
• Bisphosphonates in chronic renal failure, S. Papapoulos (NL)
  
  
• Pharmaco-genomics, M.L. Brandi (Italy)
  
  
• Vertebro/kyphoplasty, S. Boonen (Belgium)
  
  
• Issues in designing and conducting clinical trials, S. Cummings (USA)
  
  
• Osteoporosis in men, E. Seeman (Australia)
  
  
• Post-fracture management, K. Akesson (Sweden)
  
  
• Fracture healing: can we influence it?, J. Goldhahn (Switzerland)
  
  
• Genetics and osteoporosis: how to assess it?, S. Ferrari (Switzerland)
  
  
• Side effects of anti fracture drugs, S. Adami (Italy)
  
  
• Developmental origins of osteoporotic fracture, C. Cooper (UK)
  
  
• Gait and falls, T. Masud (UK)

Don't miss the premiere global skeletal health meeting of 2010 - reserve May 5-8, 2010 on your calendar.

Notes:

Abstract submission deadline: February 4, 2010.

ABOUT IOF

The International Osteoporosis Foundation (IOF) is a nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members - committees of scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. Launched in 1998 with the merger of the European Foundation for Osteoporosis (EFFO, founded in 1987) and the International Federation of Societies on Skeletal Diseases, IOF now represents 191 societies in 91 locations.

ABOUT ESCEO

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

Source:
L. Misteli
International Osteoporosis Foundation

• Additional
• References
• Citations